Tech Company Financing Transactions
Atrandi Biosciences Funding Round
Atrandi Biosciences secured a $4.8 million Series A funding round on 3/28/2023. Investors included Metaplanet, Practica Capital and Vsquared Ventures.
Transaction Overview
Company Name
Announced On
3/28/2023
Transaction Type
Venture Equity
Amount
$4,800,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to support a worldwide commercial organisation, enabling a direct U.S. presence.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Vilnius, Vilniaus Apskritis, Undisclosed
Lithuania
Vilnius, Vilniaus Apskritis, Undisclosed
Lithuania
Phone
Undisclosed
Website
Email Address
Overview
Atrandi Biosciences is a Lithuanian biotech startup that aims to commercialize droplet microfluidics technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Juozas Nainys
Chief Scientific Officer
Rapolas Zilionis
Chief Technical Officer
Karolis Leonavicius
Browse more venture capital transactions:
Prev: 3/28/2023: Carbonaide venture capital transaction
Next: 3/28/2023: FedML venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC transactions reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs